The Link Between Novel Coronavirus SARS-CoV-2 Infection and Endothelial Dysfunction in ICU-Admitted COVID-19 Patients: A Key for Hypercoagulability and Thrombosis
Clinical and Applied Thrombosis/Hemostasis · 2026-01 · 32
DOI: 10.1177/10760296261508904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 12.11.2026. Verfasst von Renad Saigh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Technology, College of Nursing and Health Sciences, Jazan University, Gizan, Saudi Arabia. Hauptthemen laut MEDLINE: Thrombophilia, Thrombosis, Endothelium, Vascular, Coronavirus Infections. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endothelial dysfunction and platelet activation contribute to the hypercoagulable state observed in severe COVID-19. This study investigated circulating P-selectin and von Willebrand factor (vWF) in ICU-admitted COVID-19 patients and examined their associations with hematological, coagulation, and in-hospital outcomes. Materials and methods A case-control study was conducted involving 140 participants, including 70 ICU-admitted COVID-19 patients and 70 healthy controls. Complete blood counts (CBC), CBC-derived parameters, coagulation profiles, D-dimer levels, and soluble plasma concentrations of P-selectin and von Willebrand factor (vWF) were measured and correlated with hematological indices in the current study.
Results
COVID-19 patients had significantly prolonged prothrombin time and activated partial thromboplastin time compared with controls (both p < 0.0001). Plasma P-selectin concentrations were significantly higher in COVID-19 patients than in controls (median 5674.50 [IQR 4778.50–6398.50] vs 3243.50 [2210.50–4332.75] pg/mL, p < 0.0001), whereas vWF concentrations did not differ significantly between groups (p = 0.1175). After adjustment for age and sex, COVID-19 status remained independently associated with higher P-selectin concentrations (adjusted ratio 1.620, 95% CI 1.319–1.989, p < 0.0001), whereas the association with vWF remained non-significant (adjusted ratio 1.533, 95% CI 0.896–2.624, p = 0.1179). Neither P-selectin nor vWF was independently associated with in-hospital mortality among COVID-19 patients with definitive outcomes.
Conclusion
ICU-admitted COVID-19 patients exhibited marked elevation of circulating P-selectin that remained significant after adjustment for age and sex, supporting an association between severe COVID-19 and platelet/endothelial activation. In contrast, vWF did not differ significantly between groups after either unadjusted or adjusted analysis. Neither biomarker independently predicted in-hospital mortality in this cohort. These findings support P-selectin as a marker of vascular and platelet activation in severe COVID-19 while highlighting the need for larger, clinically well-characterized cohorts to determine its prognostic utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Technology, College of Nursing and Health Sciences, Jazan University, Gizan, Saudi Arabia.
- Laboratory Department, Jazan University Hospital, Gizan, Saudi Arabia.
- Health Research Center, Jazan University, Gizan, Saudi Arabia.
- Department of Clinical Laboratory Sciences, Najran University, Najran, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
ORCID-Profile: Yara Alyahyawi, Fahd Alaajam, Gasim Dobie
Zitieren
APA
Saigh, R., Kameli, N., Hamali, H. A., Mobarki, A. A., Essawi, K., Hakami, W., Alyahyawi, Y., Madkhali, A. M., Alaajam, F., Nahari, M. H., Hakami, A. R., & Dobie, G. (2026). The Link Between Novel Coronavirus SARS-CoV-2 Infection and Endothelial Dysfunction in ICU-Admitted COVID-19 Patients: A Key for Hypercoagulability and Thrombosis. Clinical and Applied Thrombosis/Hemostasis, 32. https://doi.org/10.1177/10760296261508904
Vancouver
Saigh R, Kameli N, Hamali HA, Mobarki AA, Essawi K, Hakami W, et al. The Link Between Novel Coronavirus SARS-CoV-2 Infection and Endothelial Dysfunction in ICU-Admitted COVID-19 Patients: A Key for Hypercoagulability and Thrombosis. Clinical and Applied Thrombosis/Hemostasis. 2026;32. doi:10.1177/10760296261508904
BibTeX
@article{Saigh2026,
author = {Saigh, Renad and Kameli, Nader and Hamali, Hassan A and Mobarki, Abdullah A and Essawi, Khaled and Hakami, Waleed and Alyahyawi, Yara and Madkhali, Aymen M and Alaajam, Fahd and Nahari, Mohammed H and Hakami, Abdulrahim R and Dobie, Gasim},
title = {The Link Between Novel Coronavirus SARS-CoV-2 Infection and Endothelial Dysfunction in ICU-Admitted COVID-19 Patients: A Key for Hypercoagulability and Thrombosis},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2026},
volume = {32},
doi = {10.1177/10760296261508904}
}
EUVIMED